These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 11422111)
1. Hormone replacement therapy and risk of falling in early postmenopausal women - a population-based study. Randell KM; Honkanen RJ; Komulainen MH; Tuppurainen MT; Kröger H; Saarikoski S Clin Endocrinol (Oxf); 2001 Jun; 54(6):769-74. PubMed ID: 11422111 [TBL] [Abstract][Full Text] [Related]
2. Relation of estrogen receptor-alpha gene polymorphism and hormone replacement therapy to fall risk and muscle strength in early postmenopausal women. Salmén T; Heikkinen AM; Mahonen A; Kröger H; Komulainen M; Saarikoski S; Honkanen R; Partanen J; Mäenpää PH Ann Med; 2002; 34(1):64-72. PubMed ID: 12014437 [TBL] [Abstract][Full Text] [Related]
3. Does hormone-replacement therapy prevent fractures in early postmenopausal women? Randell KM; Honkanen RJ; Kröger H; Saarikoski S J Bone Miner Res; 2002 Mar; 17(3):528-33. PubMed ID: 11874244 [TBL] [Abstract][Full Text] [Related]
4. Risk factors associated with peri- and postmenopausal bone loss: does HRT prevent weight loss-related bone loss? Sirola J; Kröger H; Honkanen R; Sandini L; Tuppurainen M; Jurvelin JS; Saarikoski S Osteoporos Int; 2003 Jan; 14(1):27-33. PubMed ID: 12577182 [TBL] [Abstract][Full Text] [Related]
5. The protective effect of hormone-replacement therapy on fracture risk is modulated by estrogen receptor alpha genotype in early postmenopausal women. Salmén T; Heikkinen AM; Mahonen A; Kröger H; Komulainen M; Saarikoski S; Honkanen R; Mäenpää PH J Bone Miner Res; 2000 Dec; 15(12):2479-86. PubMed ID: 11127213 [TBL] [Abstract][Full Text] [Related]
6. Hormone replacement therapy and risk for coronary heart disease. Data from the CORA-study--a case-control study on women with incident coronary heart disease. Windler E; Zyriax BC; Eidenmüller B; Boeing H Maturitas; 2007 Jul; 57(3):239-46. PubMed ID: 17292571 [TBL] [Abstract][Full Text] [Related]
7. Recency and duration of postmenopausal hormone therapy: effects on bone mineral density and fracture risk in the National Osteoporosis Risk Assessment (NORA) study. Barrett-Connor E; Wehren LE; Siris ES; Miller P; Chen YT; Abbott TA; Berger ML; Santora AC; Sherwood LM Menopause; 2003; 10(5):412-9. PubMed ID: 14501602 [TBL] [Abstract][Full Text] [Related]
8. Multimorbidity predicts falls differentially according to the type of fall in postmenopausal women. Afrin N; Honkanen R; Koivumaa-Honkanen H; Lukkala P; Rikkonen T; Sirola J; Williams LJ; Kröger H Maturitas; 2016 Sep; 91():19-24. PubMed ID: 27451317 [TBL] [Abstract][Full Text] [Related]
9. Effects of physical activity and menopausal hormone replacement therapy on postural stability in postmenopausal women--a cross-sectional study. Brooke-Wavell K; Prelevic GM; Bakridan C; Ginsburg J Maturitas; 2001 Jan; 37(3):167-72. PubMed ID: 11173178 [TBL] [Abstract][Full Text] [Related]
10. Role of musculoskeletal disorders in falls of postmenopausal women. Afrin N; Honkanen R; Koivumaa-Honkanen H; Sund R; Rikkonen T; Williams L; Kröger H Osteoporos Int; 2018 Nov; 29(11):2419-2426. PubMed ID: 30014157 [TBL] [Abstract][Full Text] [Related]
11. Effect of hormone therapy on postural balance in postmenopausal women. Rodrigues Barral AB; Nahas EA; Nahas-Neto J; Cangussu LM; Buttros Dde A Menopause; 2012 Jul; 19(7):768-75. PubMed ID: 22473249 [TBL] [Abstract][Full Text] [Related]
12. Interaction of nutritional calcium and HRT in prevention of postmenopausal bone loss: a prospective study. Sirola J; Kröger H; Sandini L; Tuppurainen M; Jurvelin JS; Saarikoski S; Honkanen R Calcif Tissue Int; 2003 Jun; 72(6):659-65. PubMed ID: 14562993 [TBL] [Abstract][Full Text] [Related]
13. Prospective 10-year study of the determinants of bone density and bone loss in normal postmenopausal women, including the effect of hormone replacement therapy. Wu F; Ames R; Clearwater J; Evans MC; Gamble G; Reid IR Clin Endocrinol (Oxf); 2002 Jun; 56(6):703-11. PubMed ID: 12072039 [TBL] [Abstract][Full Text] [Related]
14. Association of circulating cellular adhesion molecules with menopausal status and hormone replacement therapy. Time-dependent change in transdermal, but not oral estrogen users. Oger E; Alhenc-Gelas M; Plu-Bureau G; Mennen L; Cambillau M; Guize L; Pujol Y; Scarabin P Thromb Res; 2001 Jan; 101(2):35-43. PubMed ID: 11342204 [TBL] [Abstract][Full Text] [Related]
15. Endometrial cancer and hormone-replacement therapy in the Million Women Study. Beral V; Bull D; Reeves G; Lancet; 2005 Apr 30-May 6; 365(9470):1543-51. PubMed ID: 15866308 [TBL] [Abstract][Full Text] [Related]
16. Hormone replacement therapy is associated with a decreased prevalence of peripheral arterial disease in postmenopausal women. Rockman CB; Maldonado TS; Jacobowitz GR; Adelman MA; Riles TS Ann Vasc Surg; 2012 Apr; 26(3):411-8. PubMed ID: 22285341 [TBL] [Abstract][Full Text] [Related]
17. Is postmenopausal estrogen therapy associated with neuromuscular function or falling in elderly women? Study of Osteoporotic Fractures Research Group. Seeley DG; Cauley JA; Grady D; Browner WS; Nevitt MC; Cummings SR Arch Intern Med; 1995 Feb; 155(3):293-9. PubMed ID: 7832601 [TBL] [Abstract][Full Text] [Related]
18. Effect of hormone replacement therapy on age-related increase in carotid artery intima-media thickness in postmenopausal women. Tremollieres FA; Cigagna F; Alquier C; Cauneille C; Pouilles J; Ribot C Atherosclerosis; 2000 Nov; 153(1):81-8. PubMed ID: 11058702 [TBL] [Abstract][Full Text] [Related]
19. Women's knowledge of and attitudes towards hormone replacement therapy. Lewin KJ; Sinclair HK; Bond CM Fam Pract; 2003 Apr; 20(2):112-9. PubMed ID: 12651782 [TBL] [Abstract][Full Text] [Related]